Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Transradial Primary Percutaneous Coronary Intervention: a Two-by-Two Factorial Placebo-Controlled Randomized Study
- 1 June 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (11) , 1520-1527
- https://doi.org/10.1016/j.amjcard.2010.01.006
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Relation of Cardiac Troponin I Measurements at 24 and 48 Hours to Magnetic Resonance–Determined Infarct Size in Patients With ST-Elevation Myocardial InfarctionThe American Journal of Cardiology, 2009
- Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarctionThe International Journal of Cardiovascular Imaging, 2009
- Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Interventions, 2008
- Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin TJournal of the American College of Cardiology, 2008
- Influence of Transmurality, Infarct Size, and Severe Microvascular Obstruction on Left Ventricular Remodeling and Function After Primary Coronary AngioplastyThe American Journal of Cardiology, 2006
- Association Between Level of Platelet Inhibition After Early Use of Abciximab and Myocardial Reperfusion in ST-Elevation Acute Myocardial Infarction Treated by Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2006
- Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary interventionCatheterization and Cardiovascular Interventions, 2004
- Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary InterventionCirculation, 2001
- Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987